Noticias de ANVS_US

Noticias del mercado

Últimas noticias sobre ANVS_US — 127 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANVS_US ✕ 127 resultados
30/04/2026 ANVS_US — Stock Titan
Annovis Bio (ANVS) seeks approval to expand 2019 equity incentive plan at 2026 meeting
29/04/2026 ANVS_US — MSN
Annovis Bio (ANVS) price target increased by 13.94% to 15.98
28/04/2026 ANVS_US — Investing.com UK ES ← EN
Annovis Bio informa datos cognitivos positivos en un ensayo temprano sobre Alzheimer

Annovis Bio reports positive cognition data in early Alzheimer’s trial

28/04/2026 ANVS_US — Investing.com Australia
Annovis Bio reports positive cognition data in early Alzheimer’s trial By Investing.com
28/04/2026 ANVS_US — The Manila Times ES ← EN
Annovis publica los resultados del ensayo de fase 2/3 sobre Alzheimer en Nature Portfolio

Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio

28/04/2026 ANVS_US — Investing.com UK
Annovis Bio reports positive cognition data in early Alzheimer’s trial By Investing.com
28/04/2026 ANVS_US — Investing.com UK
Annovis Bio reports positive cognition results in early Alzheimer’s trial By Investing.com
28/04/2026 ANVS_US — MarketScreener
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026 ANVS_US — MarketBeat ES ← EN
Annovis Bio, Inc. (NYSE:ANVS) ve un aumento significativo en el interés a corto plazo

Annovis Bio, Inc. (NYSE:ANVS) Sees Significant Increase in Short Interest

28/04/2026 ANVS_US — TMX Newsfile
Annovis Bio Announces Transfer of Listing to the New York Stock Exchange
28/04/2026 ANVS_US — GlobeNewswire
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026 ANVS_US — Investing.com
Annovis Bio reports positive cognition results in early Alzheimer’s trial
28/04/2026 ANVS_US — Stock Titan
Annovis drug showed cognition gains in early AD; 80% enrolled in Phase 3
28/04/2026 ANVS_US — Investing.com
Annovis Bio reports positive cognition data in early Alzheimer’s trial By Investing.com
28/04/2026 ANVS_US — The Manila Times
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026 ANVS_US — Investing.com
Annovis Bio reports positive cognition data in early Alzheimer’s trial
28/04/2026 ANVS_US — Investing.com Australia
Annovis Bio reports positive cognition results in early Alzheimer’s trial By Investing.com
28/04/2026 ANVS_US — TMX Newsfile
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
28/04/2026 ANVS_US — TMX Newsfile
Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022)
28/04/2026 ANVS_US — TMX Newsfile
Annovis Bio to Participate in the Biotech Showcase and H.C. Wainwright Bioconnect Virtual Conferences

Página 2 de 7

keyboard_arrow_up